{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:11:46Z","timestamp":1771297906233,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.taap.2024.116900","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T07:08:00Z","timestamp":1710745680000},"page":"116900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS\/ TGF-\u03b2 \/ Smad4 signaling pathway"],"prefix":"10.1016","volume":"485","author":[{"given":"Sherin","family":"Zakaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Elshazly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Alaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Elsebaey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.taap.2024.116900_bb0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10787-018-0469-x","article-title":"Oxidative stress as a possible mechanism of statin-induced myopathy","volume":"26","author":"Ahmadi","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12872-020-01825-2","article-title":"The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey","volume":"21","author":"Al-Zahrani","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"issue":"32","key":"10.1016\/j.taap.2024.116900_bb0015","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.2174\/0929867330666221129094921","article-title":"Effect of statins on the blood lipid profile in patients with different cardiovascular diseases: a systematic review with Meta-analysis of randomized clinical trials","volume":"30","author":"Aslani","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328010c559","article-title":"Myotoxicity associated with lipid-lowering drugs","volume":"19","author":"Baer","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.taap.2024.116900_bb0025","series-title":"Churchil Livingstone","author":"Banchroft","year":"1996"},{"key":"10.1016\/j.taap.2024.116900_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.778740","article-title":"Cerebrovascular disease and statins","volume":"8","author":"Beltr\u00e1n Romero","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.taap.2024.116900_bb0035","first-page":"1397","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a \u2018mitohormesis\u2019 mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"Bouitbir","year":"2012"},{"issue":"3","key":"10.1016\/j.taap.2024.116900_bb0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0014-2999(89)90260-4","article-title":"Effects of dantrolene sodium in rodent models of cardiac arrhythmia","volume":"164","author":"Brooks","year":"1989","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.116900_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4062\/biomolther.2015.089","article-title":"Effect of coenzyme Q10 supplementation in statin-treated obese rats","volume":"24","author":"Choi","year":"2016","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.taap.2024.116900_bb0050","first-page":"53","article-title":"The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations","volume":"3","author":"De Castro-Or\u00f3s","year":"2010","journal-title":"Appl. Clin. Genet."},{"issue":"3","key":"10.1016\/j.taap.2024.116900_bb0055","first-page":"191","article-title":"Overview of the Molecular Modalities and Signaling Pathways Intersecting with &beta;-Amyloid and Tau Protein in Alzheimer&rsquo;s Disease","volume":"4","author":"Elshazly","year":"2023"},{"key":"10.1016\/j.taap.2024.116900_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113526","article-title":"Rosuvastatin and co-enzyme Q10 improve high-fat and high-fructose diet-induced metabolic syndrome in rats via ameliorating inflammatory and oxidative burden","volume":"153","author":"Fahmy","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5485","key":"10.1016\/j.taap.2024.116900_bb0065","first-page":"728","article-title":"Effect of dantrolene sodium on calcium movements in single muscle fibres","volume":"252","author":"Hainaut","year":"1974"},{"issue":"5","key":"10.1016\/j.taap.2024.116900_bb0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11883-010-0120-9","article-title":"Evidence-based Management of Statin Myopathy","volume":"12","author":"Harper","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1\u20134","key":"10.1016\/j.taap.2024.116900_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/biof.5520320124","article-title":"Safety assessment of coenzyme Q10 (CoQ10)","volume":"32","author":"Hidaka","year":"2008","journal-title":"Biofactors"},{"issue":"6","key":"10.1016\/j.taap.2024.116900_bb0080","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1213\/ANE.0b013e3181f7181c","article-title":"The cytoprotective effects of dantrolene: a ryanodine receptor antagonist","volume":"111","author":"Inan","year":"2010","journal-title":"Anesth. Analg."},{"issue":"12","key":"10.1016\/j.taap.2024.116900_bb0085","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.taap.2024.116900_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.03.006","article-title":"Effect of coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: a systematic review and meta-analysis","volume":"299","author":"Kennedy","year":"2020","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1381612827666210804095300","article-title":"RYR1-related rhabdomyolysis: a Spectrum of hypermetabolic states due to ryanodine receptor dysfunction","volume":"28","author":"Kruijt","year":"2022","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0000000000000076","article-title":"Dantrolene, a treatment for Alzheimer disease?","volume":"29","author":"Liang","year":"2015","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"2","key":"10.1016\/j.taap.2024.116900_bb0105","first-page":"626","article-title":"Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum\/mitochondria Ca2+\u2212release system","volume":"321","author":"Liantonio","year":"2007"},{"key":"10.1016\/j.taap.2024.116900_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.taap.2024.116900_bb0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.14310\/horm.2002.1170","article-title":"Dyslipidemia in patients with thyroid disorders","volume":"1","author":"Liberopoulos","year":"2002","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.taap.2024.116900_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2018.10.004","article-title":"Statins: adverse reactions, oxidative stress and metabolic interactions","volume":"195","author":"Liu","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.taap.2024.116900_bb0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jacbts.2019.03.012","article-title":"A mechanism for statin-induced susceptibility to myopathy","volume":"4","author":"Lotteau","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"23","key":"10.1016\/j.taap.2024.116900_bb0130","first-page":"2231","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007"},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0135","first-page":"286","article-title":"Effect of simvastatin on the skeletal muscles of senile male albino rats and possible protective role of L-carnitine. A histological study %J Egyptian","volume":"43","author":"Mehanna","year":"2020","journal-title":"Journal. Hist."},{"key":"10.1016\/j.taap.2024.116900_bb0140","doi-asserted-by":"crossref","first-page":"9726137","DOI":"10.1155\/2019\/9726137","article-title":"Effectiveness of<i> Coelatura aegyptiaca<\/i> extract combination with atorvastatin on experimentally induced hyperlipidemia in rats","volume":"2019","author":"Mohamed","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.taap.2024.116900_bb0145","doi-asserted-by":"crossref","first-page":"9726137","DOI":"10.1155\/2019\/9726137","article-title":"Effectiveness of Coelatura aegyptiaca extract combination with atorvastatin on experimentally induced hyperlipidemia in rats","volume":"2019","author":"Mohamed","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1\u20132","key":"10.1016\/j.taap.2024.116900_bb0150","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1503\/cmaj.081785","article-title":"Association between statin-associated myopathy and skeletal muscle damage","volume":"181","author":"Mohaupt","year":"2009","journal-title":"Cmaj"},{"issue":"2","key":"10.1016\/j.taap.2024.116900_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/mol.115.097691","article-title":"Essential role of calmodulin in RyR inhibition by Dantrolene","volume":"88","author":"Oo","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2024.116900_bb0170","first-page":"36","article-title":"Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways","volume":"83","author":"Pal","year":"2015"},{"key":"10.1016\/j.taap.2024.116900_bb0175","first-page":"20","article-title":"Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways","volume":"112","author":"Pal","year":"2015"},{"issue":"19","key":"10.1016\/j.taap.2024.116900_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009835","article-title":"Effects of coenzyme Q10 on statin-induced myopathy: an updated Meta-analysis of randomized controlled trials","volume":"7","author":"Qu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.taap.2024.116900_bb0185","first-page":"75","article-title":"Statins, muscle disease and mitochondria","volume":"6","author":"Ramachandran","year":"2017"},{"issue":"12","key":"10.1016\/j.taap.2024.116900_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003959","article-title":"Essential role of TGF-beta\/Smad pathway on statin dependent vascular smooth muscle cell regulation","volume":"3","author":"Rodr\u00edguez-Vita","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.taap.2024.116900_bb0195","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","article-title":"Current overview of statin-induced myopathy","volume":"116","author":"Rosenson","year":"2004","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.taap.2024.116900_bb0200","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2005.02.070","article-title":"Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle","volume":"329","author":"Sirvent","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.taap.2024.116900_bb0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1037\/1064-1297.10.4.385","article-title":"Dantrolene diminishes forelimb force-related tremor at doses that do not decrease operant behavior in the rat","volume":"10","author":"Stanford","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.taap.2024.116900_bb0210","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.taap.2024.116900_bb0215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4103\/0970-9185.194773","article-title":"Current and emerging treatments for hypercholesterolemia: a focus on statins and proprotein convertase subtilisin\/kexin type 9 inhibitors for perioperative clinicians","volume":"32","author":"Trentman","year":"2016","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.taap.2024.116900_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104477","article-title":"Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury","volume":"254","author":"Wei","year":"2022","journal-title":"J. Proteome"},{"issue":"2","key":"10.1016\/j.taap.2024.116900_bb0230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/01926230590908213","article-title":"Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity","volume":"33","author":"Westwood","year":"2005","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.taap.2024.116900_bb0235","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2174\/1874467214666210126110627","article-title":"Dantrolene potentiates the antineoplastic effect of Sorafenib in hepatocellular carcinoma via targeting ca(+2)\/PI3K signaling pathway","volume":"14","author":"Zakaria","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116900_bb0240","first-page":"1","article-title":"The sarcoplasmic reticulum Ca2+ channel\/ryanodine receptor: modulation by endogenous effectors, drugs and disease states","volume":"49","author":"Zucchi","year":"1997","journal-title":"Pharmacol. Rev."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2400098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2400098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T12:32:53Z","timestamp":1713961973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2400098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"alternative-id":["S0041008X2400098X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116900","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS\/ TGF-\u03b2 \/ Smad4 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116900"}}